Targeting Immune Checkpoints in Cancer Therapy
Author:
Affiliation:
1. Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland2The Johns Hopkins Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland
Publisher
American Medical Association (AMA)
Subject
General Medicine
Cited by 110 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Neuromedin U receptor 1 deletion leads to impaired immunotherapy response and high malignancy in colorectal cancer;iScience;2024-07
2. Comprehensive pan-cancer analysis reveals that C5orf34 regulates the proliferation and mortality of lung cancer;Functional & Integrative Genomics;2024-06-29
3. A novel ferroptosis-related gene signature for overall survival prediction in patients with gastric cancer;Scientific Reports;2024-02-23
4. The Biology of Immune Checkpoint Blockade;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21
5. Establishing a carcinoembryonic antigen-associated competitive endogenous RNA network and forecasting an important regulatory axis in colon adenocarcinoma patients;Journal of Gastrointestinal Oncology;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3